HEALTHFINANCIAL TIMES WORLD
NHS England adds caveat to pro-Palantir data after watchdog probe
NHS England has added a caveat to data supporting Palantir following a watchdog investigation. A regulator has urged the health service to ensure communications about the benefits of Palantir are 'clearly and appropriately labelled'.
Mentioned
Related Signal
Adjacent reporting
- Palantir’s access to identifiable NHS England patient data is ‘dangerous’, MPs say
- NHS patients can't opt out of Palantir's data platform – but their hospital can
- Palantir’s access to identifiable NHS England patient data is ‘dangerous’, MPs say
- NHS England confirms: Palantir staff can access patient data
- NHS England admits key data does not prove Palantir’s effectiveness
- UK government adviser urges clarity on Palantir access to NHS patient data